WHY NAMASTE?

• Company’s sales for the second quarter of 2018 were $5.6M,
  • representing a $3.7M or 195% increase quarter-over-quarter. 
• Gross profit for the second quarter of 2018 was $1.9M, representing a $1.2M or 150% increase quarter-on-quarter.
• Wholly owned subsidiary, Cannmart has received its Access to Cannabis for Medical Purposes Regulations Production License
• Closed its previously announced acquisition of Swedish-based A.I. and machine learning technology platform, Findify AB
• Signed a non-binding letter of intent with Pineapple Express Delivery Inc
• Signed a Medical Cannabis Supply Agreement with Marigold Projects Jamaica Ltd.
• Non-Binding Letter of Intent With O Cannabis Clinic for Management Services
• Aurora and Namaste to Complete Strategic Private-Label Software and Patient Referral Agreements
  Announces Wholesale Supply LOI With Israel-Based BRLEV
• Owns 26 e-commerce stores in 20 countries
• Distribution centers in North America, South America, Europe and Asia Pacific
• Aggressively expanding into manufacturing and wholesaling
• Product acquisition agreement announced with Aphria Inc.
• Announced Start of Vaporizer Sales through Aurora Website
• Joint Venture Agreement with one of Israel’s premier online vaporizer retailers, Vaporiza.co.il
• Acquired the domain and customer database of Brazil’s largest vaporizer retailer, vaptvupt.lojaintegrada.com.br
• Divests US Assets to Focus on Legal Cannabis Markets

NAMASTE MD

• 2018 will focus on establishing Namaste MD, the secure telemedicine portal designed to connect doctors with medical marijuana patients.
  • After an application and video consultation, Canadian patients can receive their medical marijuana recommendation via email.
  • They can also receive their prescription (fulfilled via CannMart) from the convenience of their homes – utilizing same-day and 2-day delivery options.
• Leveraging 50,000+ dataset of Canadian consumers, Namaste will strive to secure space as Canada’s one-stop-shop for medical cannabis.